Product Information
APRI 28 DAY TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1353 per EA under NDC 00555904358. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 12, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Desogestrel and Ethinyl Estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555904358
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075256FDA Approved
8/12/1999
TE Code
AB
On Market Since
10/22/1999
Price Statistics
The NADAC for APRI 28 DAY TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 72.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1353 per EA |
|---|---|
| All-time high | $0.4912 (Aug 10, 2016) |
| All-time low | $0.1111 (Nov 20, 2024) |
| 52-week high | $0.1544 |
| 52-week low | $0.1299 |
| Median price | $0.2828 |
| Average price | $0.2909 |
| Largest weekly change | -31.0% (Sep 23, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desogestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of APRI 28 DAY TABLET?
The current National Average Drug Acquisition Cost (NADAC) for APRI 28 DAY TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1353 per EA (NDC 00555904358), effective Sep 30, 2026.
How has the price of APRI 28 DAY TABLET changed over time?
Over the history we have for it, the NADAC for APRI 28 DAY TABLET has declined 72.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for APRI 28 DAY TABLET?
Since Nov 28, 2013, the NADAC for APRI 28 DAY TABLET has ranged from a low of $0.1111 (Nov 20, 2024) to a high of $0.4912 (Aug 10, 2016), with a median of $0.2828 per EA.
Are there cheaper alternatives to APRI 28 DAY TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as APRI 28 DAY TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures APRI 28 DAY TABLET?
APRI 28 DAY TABLET (NDC 00555904358) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.